Bioavailability, crucial in pharmacology and nutrition, determines how efficiently a substance enters the bloodstream and reaches its target. In pharmaceuticals, it measures the portion of a dose that achieves systemic circulation, overcoming challenges like liver metabolism and gastrointestinal obstacles. Optimizing bioavailability is essential in drug formulation to ensure intended therapeutic effects. In nutrition, bioavailability governs the body's efficiency in absorbing essential nutrients from ingested food, impacted by factors like food processing and individual variations, influencing overall health. Understanding bioavailability involves exploring absorption mechanisms, bodily fluid transport, and metabolic interplay. Researchers enhance it through innovative delivery systems, considering substance solubility and tailoring formulations for optimal absorption rates.
In essence, whether in pharmaceuticals or nutrition, bioavailability is a dynamic and intricate parameter crucial for maximizing therapeutic impact or nutritional benefit. Its mastery reflects the delicate dance between scientific understanding, precise formulation, and the complex physiological intricacies of the human body.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico